For instance, the AASK study of African Americans, which investigated the cardiovascular and renal outcomes of 59,508 participants with stage 1–3 CKD, indicated a significantly increased risk of CVD with higher urinary albumin excretion, despite relatively low levels of baseline proteinuria [31]. This evidence concerns the gene ALB and chronic kidney disease.